NeurAxon Inc., a biotech start-up focused on new treatments for pain, has raised C$2.5 million ($1.8 million) in its first round of outside venture funding.
NeurAxon Inc., a biotech start-up focused on new treatments for pain, has raised C$2.5 million ($1.8 million) in its first round of outside venture funding.
